文献速递焦虑、强迫与应激相关障碍会诊联络精神医学

强迫症与代谢及心血管并发症:全国性同胞对照长期随访研究

Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up.
PubMed 文献 · Biol Psychiatry · 2017-12-21

该研究基于瑞典1973至2013年间12497002人的队列,识别出25415名强迫症患者,采用Cox比例风险回归比较其与一般人群及未患病同胞的代谢和心血管并发症风险。结果显示强迫症患者发生任意代谢或心血管并发症的风险显著升高,且肥胖、2型糖尿病和循环系统疾病风险在同胞对照中仍显著;较高剂量和较长疗程的5-羟色胺再摄取抑制剂治疗与较低风险相关。

要点

  • 强迫症患者代谢和心血管并发症风险较一般人群及未患病同胞均显著升高。
  • 同胞对照中肥胖、2型糖尿病和循环系统疾病风险仍显著增加。
  • 较高剂量和较长疗程的5-羟色胺再摄取抑制剂治疗与较低并发症风险相关。

核心结论

  • 强迫症与代谢和心血管并发症风险增加相关。
  • 结果强调在强迫症病程早期仔细监测代谢和心血管健康的重要性。

研究设计与样本

  • 基于瑞典1973至2013年间12497002人的总人口队列,识别25415名强迫症患者。
  • 采用Cox比例风险回归分析,比较强迫症患者与一般人群及未患病全职同胞的代谢和心血管并发症风险。
  • 探索性分析评估5-羟色胺再摄取抑制剂(联合或不联合抗精神病药)治疗对结局的影响。

主要发现

  • 强迫症患者发生任意代谢或心血管并发症的风险高于一般人群(调整后风险比=1.45;95%置信区间=1.42-1.49)。
  • 强迫症患者发生任意代谢或心血管并发症的风险高于未患病全职同胞(调整后风险比=1.47;95%置信区间=1.40-1.54)。
  • 在完全调整的同胞比较模型中,患者肥胖、2型糖尿病和循环系统疾病风险更高。
  • 风险从随访开始时即已显现,排除不同精神科共病组后基本不变。
  • 与未服用5-羟色胺再摄取抑制剂的患者相比,服用较高剂量且治疗时间较长的患者代谢和心血管并发症风险显著较低,无论是否联用抗精神病药。

关键数值与推荐

  • 任意代谢或心血管并发症:一般人群比较调整后风险比=1.45(95%置信区间=1.42-1.49)。
  • 任意代谢或心血管并发症:未患病全职同胞比较调整后风险比=1.47(95%置信区间=1.40-1.54)。

临床怎么用

  • 对强迫症患者应在病程早期即关注并监测代谢和心血管健康。
  • 评估强迫症患者时需考虑肥胖、2型糖尿病和循环系统疾病的风险筛查。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Obsessive-compulsive disorder (OCD) is associated with increased mortality, but the causes of this increase are poorly understood. This study examined whether OCD is associated with an increased risk of metabolic and cardiovascular complications. METHODS: Individuals diagnosed with OCD (n = 25,415) were identified from a cohort of 12,497,002 individuals living in Sweden between 1973 and 2013. Cox proportional hazard regression analyses were used to investigate the risk of metabolic and cardiovascular complications in OCD patients compared with the general population and unaffected full siblings of OCD individuals. Exploratory analyses were used to examine the effect of treatment with serotonin reuptake inhibitors, with or without antipsychotics, on the outcomes of interest. RESULTS: Individuals with OCD had a higher risk of any metabolic or cardiovascular complications compared with the general population (adjusted hazard ratio = 1.45; 95% confidence interval = 1.42-1.49) and their unaffected full siblings (adjusted hazard ratio = 1.47; 95% confidence interval = 1.40-1.54). In the fully adjusted sibling comparison models, patients had higher risks of obesity, type 2 diabetes mellitus, and circulatory system diseases. The risks were already evident from the beginning of the follow-up period and remained largely unchanged when excluding different groups of psychiatric comorbidities. Compared with patients who were not taking serotonin reuptake inhibitors, patients taking higher doses of serotonin reuptake inhibitors and who had a longer duration of treatment had significantly lower risks of metabolic and cardiovascular complications, regardless of whether they were also taking antipsychotics. CONCLUSIONS: OCD is associated with an increased risk of metabolic and cardiovascular complications. Our results underscore the importance of carefully monitoring metabolic and cardiovascular health in patients with OCD early in the course of the disorder.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Isomura K, Brander G, Chang Z, et al. Metabolic and Cardiovascular Complications in Obsessive-Compulsive Disorder: A Total Population, Sibling Comparison Study With Long-Term Follow-up. Biol Psychiatry. 2017. PMID: 29395042. doi:10.1016/j.biopsych.2017.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。